Chemicals and Drugs

Inotuzumab Ozogamicin

Immunotoxin that consists of anti-CD22 (CD22 ANTIGEN) humanized monoclonal antibody covalently linked to the antineoplastic antibiotic CALICHEAMICIN. It is used for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (LEUKEMIA, ACUTE LYMPHOBLASTIC).

National Library of MedicineMedical Subject Headings2026

Structured Summary

Abstract

Immunotoxin that consists of anti-CD22 (CD22 ANTIGEN) humanized monoclonal antibody covalently linked to the antineoplastic antibiotic CALICHEAMICIN. It is used for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (LEUKEMIA, ACUTE LYMPHOBLASTIC).

MeSH Record

Classification

Broader headings

Related Concepts

Knowledge Graph

Loading graph…

Drag nodes to rearrange; hover to trace links; click a node to open its page.

Drug Class

Pharmacological Action

MeSH Record

Synonyms

4 entry terms
  • Besponsa
  • CMC-544
  • CMC544
  • CMC 544

MeSH Record

Aspects Covered

22 allowable subheadings

Indexed with the subheadings administration & dosage, adverse effects, analysis, blood, cerebrospinal fluid, chemistry, classification, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, therapeutic use, toxicity, ultrastructure, urine.

MeSH Record

History Note

2020 (2004)

MeSH Hierarchy

Tree Numbers

  1. D09w.408w.051.247w.750w
  2. D12.776w.124w.486.485.114w.224w.060w.794w
  3. D12.776w.124w.790.651.114w.224w.060w.794w
  4. D12.776w.377w.715.548.114w.224w.200w.794w

AMA Style

References

  1. National Library of Medicine. Inotuzumab Ozogamicin. Medical Subject Headings (MeSH). 2026. Unique ID D000080045. http://id.nlm.nih.gov/mesh/2026/D000080045
  2. Inotuzumab Ozogamicin. In: Wikipedia. https://en.wikipedia.org/wiki/Inotuzumab_ozogamicin
  3. Inotuzumab Ozogamicin. In: Wikidata. https://www.wikidata.org/wiki/Q3799041